Le Lézard
Classified in: Health
Subjects: NPT, WOM

The Endometriosis Foundation of America Joins 2018 Berlin Marathon


NEW YORK, Feb. 22, 2018 /PRNewswire-iReach/ -- The Endometriosis Foundation of America (EndoFound) announced today its partnership in the 45th Annual 2018 BMW Berlin Marathon in Berlin Germany on September 16th, 2018.   

The Endometriosis Foundation of America Joins 2018 Berlin Marathon

Whether you're a seasoned runner looking to improve your personal best or an enthusiastic beginner just getting into the marathon scene, the 26-mile run through historic Berlin Germany offers a unique running experience. Starting at Brandenburg Gate and passing by iconic landmarks including the Reichstag, Potsdamer Platz, and Berlin Cathedral, you will be one of over 40,000 runners racing together from around the world!

Secure your guaranteed entry in this sold-out race as part of the EndoFound Berlin Marathon Charity team.  Accepted runners will be required to meet a personal fundraising commitment of $1500 as they train to run an iconic marathon for endometriosis awareness and research.

Endometriosis affects one in ten women, is the third leading cause of female infertility and is one of the most misdiagnosed diseases.   EndoFound strives to increase disease recognition, provide advocacy, facilitate expert surgical training, and fund landmark endometriosis research.

To apply to team EndoFound visit EndoFound.org or call 646.854.3337.

The BMW BERLIN-MARATHON belongs to the Abbott World Marathon Majors (Abbott WMM).  

Media Contact: Jeanne Rebillard, Endometriosis Foundation Of America, 845-518-4636, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Endometriosis Foundation of America


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: